Metformin was approved by the US FDA in 1994 for having the ability to reduce blood glucose.and fasting plasma glucose. It can improve the effectiveness of insulin in the body.However when used alone it does not increase the strength of blood insulin neither does it produce excessively low blood glucose amounts. Metformin performs by reducing the amount of glucose that is produced in the liver and by making body cells more sensitive to insulin. liver

RQSolutions is a tenet of strategic professionals with over 25 years in medical device registration, medical device consulting services, therapeutic goods registration and administration, ISO 13485 compliance and quality management in the health care industry.

Pharmaffiliates Analytics & Synthetics offers pharma research, custom synthesis, impurity synthesis, method development, method validation, stability studies and all other pharmaceutical services across the globe.